Session 3: Malignant Transformation in WM

The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Session 3: Malignant Transformation in WM:

Session Chair: Linda Pilarski (Canada)

What phenotypic and genomic changes define transformation from IgM MGUS to symptomatic WM? B. Paiva (Spain)

Does the mutational landscape change with evolution of IgM MGUS to active WM? C. Jimenez (Spain)

Does transcriptome-wide analysis demonstrate significant differences in gene expression variability between WM and IgM MGUSBM B cell clones? A. Trojani (Italy)

Clonal complexity in Waldenstrom macroglobulinemia and potential therapeutic options L. Pilarski (Canada)

Amsterdam 2016 Overview

Click here to display the Amsterdam 2016 Overview page

Click here to display the Amsterdam-2016 Conference Highlights

Amsterdam 2016 Organizers

MJ Kersten MD, Ph.D (U. Amsterdam)
Monique Minnema MD, Ph.D (UMC Utrecht)
Steven Pals MD, Ph.D (U. Amsterdam)
Steven Treon MD, Ph.D (Dana-Farber)
Chris Patterson - Secretariat (Dana-Farber)

Amsterdam 2016 Faculty

The Amsterdam 2016 Scientific Committee members:

Stephen Ansell MD, PhD (USA)
Christian Buske MD, PhD (Germany)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Xavier Leleu MD, PhD (France)
Mary McMaster MD, PhD (USA)
Giampaolo Merlini MD (Italy)
Monique Minnema MD, PhD (Netherlands)
Enrica Morra MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Linda Pilarski PhD (Canada)
Steven Treon MD PhD (USA)

Amsterdam 2016 Program

Click here to download the preliminary program agenda for the 9th International Workshop on WM (IWWM-9).

Amsterdam 2016 Sponsors

Click here to display the sponsors for the 9th International Workshop on WM (IWWM-9).

Amsterdam 2016 Abstracts

Choose from the following list of IWWM-9 (Amsterdam 2016) conference sessions:

Symposium on Advances in Multiple Myeloma

Session 1: Diagnostic Workup of WM

Session 2: Predisposition in WM

Session 3: Malignant Transformation in WM

Session 4: Genomic Landscape in WM

Session 5: Plenary Talks

Session 6: Keynote Lectures: Myddosome Signaling: What have we learned?

Session 7: CXCR4 WHIM mutations and WM Pathogenesis

Session 8: Non-MYD88 and CXCR4 Signaling in WM

Session 9: BTK directed Therapy in WM

Session 10: Short Oral Discussion of Selected Poster Abstracts

Session 11: Novel Therapeutic approaches for WM

Session 12: Great Debate I - What should be the frontline standard for treatment of WM?

Session 12: Great Debate II - What should be the goal of therapy in 2017 for WM patients?

Session 13: Management of Specific Disease Morbidities in WM (Part 1)

Session 14: Management of Specific Disease Morbidities in WM (Part 2)

Session 15: Discussion: When should autologous transplant be offered to WM patients?

Amsterdam 2016 Registration

Registration is closed for this event.

Amsterdam 2016 Hotel & Travel

Amsterdam 2016 (IWWM-9) was held at the Renaissance Hotel in Amsterdam.

Renaissance Hotel Amsterdam

Please enjoy this interactive sightseeing map of Amsterdam:

Interactive Map of Amsterdam

Amsterdam 2016 Media Gallery

Please select the gallery to be viewed. Special thanks to Roger Brown (WMUK) and Bob Manning (Bing Ctr) for contributing to the photos.

IWWM-9 Opening Ceremonies

IWWM-9 Presenters

IWWM-9 Speakers Reception

IWWM-9 Poster Session

IWWM-9 Conference Scenes

IWWM-9 Closing Ceremonies

International Doctor-Patient Forum

The following slide presentations given at the Doctor-Patient Forum can be viewed by clicking the desired presentation:

About the IWMF Carl Harrington

WM Diagnostics, Symptoms, & Treatment Criteria Ramon Garcia-Sanz

Predispositions: Familial & Secondary Cancers Robert Kyle

Biomarkers & Genomic Targets: MYD88 & CXCR4 Zachary Hunter

Disease Morbidities I: PN, Bing-Neel, Renal Monique Minnema

Upfront Treatment Approaches Jorge Castillo

Relapsed Refractory Approaches MJ Kersten

Disease Morbidities II: Amyloid, IgM Related Disorders, Hyperviscosity and Cryos Josephine Vos

Self-Management: Fitness, Supplements, Diet & Fatigue Toni Dubeau

New York 2018 Overview

Click here to display the New York 2018 Overview page

New York 2018 Organizers

New York 2018 Conference Chairs

Jorge Castillo, MD (Dana-Farber)
Richard Furman, MD (Cornell University)
M. Lia Palomba, MD (Memorial Sloan Kettering)
Steven Treon, MD, PhD (Dana-Farber)
Chris Patterson - Secretariat (Dana-Farber)

New York 2018 Scientific Committee

The New York 2018 Scientific Committee members:

Ranjana Advani, MD (USA)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Zachary Hunter, PhD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Giampaolo Merlini MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Marvin Stone, MD (USA)
Marzia Varretoni, MD (Italy)

New York 2018 Program

Click here to download the IWWM-10 New York 2018 Program

New York 2018 Sponsors

Click here to display the sponsors for the 10th International Workshop on WM (IWWM-10).

New York 2018 Abstracts

Choose from the following list of New York 2018 (IWWM-10) conference sessions:

Session 1: Genomics in the Diagnosis and Management of WM

Session 2: Predisposition to WM

Session 3: Disease Presentation in WM

Session 4: Genomic Landscape of WM

Session 5: Mechanisms of Tumor Growth and Survival in WM

Session 6: Oral Presentations of Selected Abstracts I